Identification of promoter region methylation patterns of MGMT, CDKN2A, GSTP1, and THBS1 genes in intracranial meningioma patients

Genetic Testing and Molecular Biomarkers

Volumn 16, Issue 5, 2012, Pages 335-340

  Aydemir, Fatih ^a   Yurtcu, Erkan ^a   Balci, Tugce Bulakbasi ^a   Sahin, Feride Iffet ^a   Gulsen, Salih ^a   Altinors, Nur ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BRAIN MENINGIOMA; CANCER GRADING; CANCER RECURRENCE; CLINICAL ARTICLE; DNA METHYLATION; FEMALE; GENETIC IDENTIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MENINGIOMA; POLYMERASE CHAIN REACTION; PROMOTER REGION; SEX DIFFERENCE; WORLD HEALTH ORGANIZATION;

ADULT; AGED; AGED, 80 AND OVER; DNA METHYLATION; DNA MODIFICATION METHYLASES; DNA REPAIR ENZYMES; EPIGENESIS, GENETIC; FEMALE; GENES, P16; GLUTATHIONE S-TRANSFERASE PI; HUMANS; MALE; MENINGIOMA; MIDDLE AGED; PROMOTER REGIONS, GENETIC; THROMBOSPONDINS; TUMOR SUPPRESSOR PROTEINS; YOUNG ADULT;

EID: 84861491217     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2011.0245     Document Type: Article

References (30)

1. Bello MJ, Aminoso C, Lopez-Marin I, et al. (2004) DNA methylation of multiple premoter-associated CpG islands in meningiomas: relationship with the allelic status at 1p and 22q. Acta Neuropathol 108:413-421.
2. Bello MJ, de Campos JM, Kusak ME, et al. (1994) Allelic loss at 1p is associated with tumor progression of meningiomas. Genes Chromosomes Cancer 9:296-298.
3. Bostrom J, Meyer-Puttlitz B, Wolter M, et al. (2001) Alterations of the tumor supressor genes CDKN2A (p16[INK4a]), p14(ARF), CDKN2B (p15(INK4b), and CDKN2C (p18[INK4c]) in atypical and anaplastic meningiomas. Am J Pathol 159:661-669.
4. Brena RM, Costello JF (2007) Genome-epigenome interactions in cancer. Hum Mol Genet Spec No 1:96-105.
5. DeRobles P, McIntyre J, Kalra S, et al. (2008) Methylation status of MGMT gene promoter in meningiomas. Cancer Genet Cytogenet 187:25-27.
6. Dumanski JP, Carlbom E, Collins VP, et al. (1987) Deletion mapping of a locus on human chromosome 22 involved in the oncogenesis of meningioma. Proc Natl Acad Sci USA 84:9275-9279.
7. Esteller M (2000) Epigenetic lesions causing genetic lesions in human cancer: promoter hypermethylation of DNA repair genes. Eur J Cancer 36:2294-2300.
8. Esteller M (2002) CpG island hypermethylation and tumor supressor genes: a booming present, a brighter future. Oncogene 21:5427-5440.
9. Esteller M (2008) Epigenetics in cancer. N Eng J Med 358:1148-1159.
10. Esteller M, Corn PG, Baylin SB, et al. (2001) A gene hypermethylation profile of human cancer. Cancer Res 61:3225-3229.
11. Esteller M, Corn PG, Urena JM, et al. (1998) Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia. Cancer Res 58:4515-4518.
12. Guo N, Krutzsch HC, Inman JK, et al. (1997) Thrombospondin 1 and type 1 repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells. Cancer Res 57:1735-1742.
13. Gutmann DH, Donahoe J, Perry A, et al. (2000) Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis ofmeningiomas.HumMolGenet 9:1495-1500.
14. Haddad GF, Al-Mefty O, Abdulrauf IS (2004) Extrinsic tumors. In: Winn HR (ed) Youmans Neurological Surgery, Fifth edition, Vol. 1. Curtis Center, PA, pp 1099-1132.
15. Lamszus K (2004) Meningioma pathology, genetics, and biology. J Neuropathol Exp Neurol 63:275-286.
16. Li Q, Ahuja N, Burger PC, et al. (1999) Methylation and silencing of the Thrombospondin-1 promoter in human cancer. Oncogene 18:3284-3289.
17. Liu Y, Pang JC, Dong S, et al. (2005) Aberrant CpG island hypermethylation profile is associated with atypical and anaplastic meningiomas. Hum Pathol 36:416-425.
18. Louis DN, Scheithauer BW, Budka H, et al. (2000) Menigiomas, pathology and genetics of tumours of the nervous system. In: Kleihues P, Cavenee WK (eds) World Health Organization Classification of Tumours. IARC Press, Lyon, pp 176-184.
19. Panetti TS, Chen H, Misenheimer TM, et al. (1997) Endothelial cell mitogenesis induced by LPA: inhibition by thrombospondin-1 and thrombospondin-2. J Lab Clin Med 29:208-216.
20. Perry A, Cai DX, Scheithauer BW, et al. (2000) DAL-1, and progesterone receptor expression in clinicopathologic subsets of meningioma: a correlative immunohistochemical study of 175 cases. J Neuropathol Exp Neurol l59:872-879.
21. Ruas M, Peters G (1998) The p161NK4a/CDKN2A tumor supressor and its relatives. Biochim Biophys Acta 1378:115-177.
22. Ruttledge MH, Sarrazin J, Rangaratnam S, et al. (1994) Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nat Genet 6:180-184.
23. Seizinger BR, de la Monte S, Atkins L, et al. (1987) Molecular genetic approach to human meningiomas: loss of genes on chromosome 22. Proc Natl Acad Sci USA 84:5419-5423.
24. Tse JY, Ng HK, Lo KW, et al. (1998) Analysis of cell cycle regulators: p16INK4A, pRb, and CDK4 in low-and high-grade meningiomas. Hum Pathol 29:1200-1207.
25. Ueki K, Wen-Bin C, Narita Y, et al. (1999) Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas. Cancer Res 59:5995-5998.
26. Wakabayashi T, Natsume A, Hatano H, et al. (2009) P16 promoter methylation in the serum as a basis for the molecular diagnosis of gliomas. Neurosurgery 64:455-461.
27. Weber RG, Bostrom J, Wolter M, et al. (1997) Analysis of genomic alterations in benign, atypical and anaplastic meningiomas. Toward a genetic model of meningioma progression. Proc Natl Acad Sci USA 94:14719-14724.
28. Wellenreuther R, Kraus JA, Lenartz D, et al. (1995) Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma. Am J PAthol 146:827-832.
29. Yin D, Xie D, Hofmann WK, et al. (2002) Methylation, expression, and mutation analysis of the cell cycle control genes in human brain tumors. Oncogene 21:8372-8378.
30. Yoshino A, Katayama Y, Ogino A, et al. (2007) Promoter hypermethylation profile of cell cycle regulator genes in pituitary adenomas. J Neurooncol 83:153-162.